Ovarian Clear Cell Carcinoma Clinical Trials in Wuhan, Hubei
2 recruitingWuhan, Hubei, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Ovarian Clear Cell Carcinoma
Tongji Hospital226 enrolled1 locationNCT07002346
Recruiting
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
Ovarian Clear Cell Carcinoma
Tongji Hospital150 enrolled1 locationNCT06279104